CCND1 and neoplasm: Our previous studies demonstrated that FBXO31 functions as a tumor suppressor in GC by targeting several important oncoproteins, such as CyclinD1 [17], Snail1 [18], and the loss of FBXO31 protein is associated with a higher malignant phenotype and poorer prognosis.